retatrutide triple hormone receptor agonist mechanism of action How Does Work? Doctor Explains Why It's So Effective Retatrutide - Wikipedia

Shaham, O

GLP-1s are not going anywhere pharma manufacturers continue to evolve their GLP-1/GIP product offerings (e.g., Eli Lillys Zepbound is the newest on the market), and the number of addressable indications is increasing (e.g., recent clinical evidence that may merit further FDA approval of GLP-1s for cardio-metabolic, nephrological and neurological indications)

OBrien R, OMalley D (2020) The glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of irritable bowel syndrome

Focus: Maintenance planning, establishing long-term strategy, evaluating results against goals

Pharmaceutical Commerce